Neurobiology
Advancing our understanding of the brain's complex circuitry
→
Explore
Our capabilities span all facets of the translation process
Expertise
From rapid prototyping, data analysis and software development, to regulatory affairs and entrepreneurship, our staff expertise enables neuroscience innovation to reach the patient.
Our facilities
Our state-of-the art facilities at Campus Biotech in Geneva house world-class translational research and support our collaborative efforts with academia and industry. Complementing our portfolio are pre-clinical and clinical platforms available at Campus Biotech and at our collaborating academic institutions and hospitals.
ALICe
State-of-the-art advanced lightsheet imaging center
→
Explore
Prototyping laboratories
Advanced electrical and mechanical engineering design and fabrication
→
Explore
Collaborating facilities
As part of the rich collaborative environment at Campus Biotech, state-of-the-art multi-user platforms - the Neural Microsystems Platform (NMP), the Preclinical Neuroscience Platform (PNP) and the Human Neuroscience Platform (HNP) - make a substantial contribution to the innovative capabilities of the Campus.
Updates
-
![2212 Wc Star 001]()
15.01.2023New project: STAR - Solutions Through Astrocyte Research
The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.
Wyss Center -
![2210 Wc Project 003]()
21.11.2022Brain-computer interfaces: New technology. More data. Improving lives.
Symposium: As the BCI community shifts its focus to clinical studies for patient benefit, join us to hear from researchers and companies working together at the forefront of BCI development discussing paths to translation and BCI home-use.
Wyss Center -
![2204 Wc Ability 003]()
09.11.2022Latest neural signals recorded with ABILITY brain-computer interface and new details of the system presented at Society for Neuroscience meeting
Wyss Center’s ABILITY system, designed to improve quality of life and independence for people with severe paralysis, demonstrates safety and efficacy in pre-clinical trials.
Technology
